FARALLON CAPITAL MANAGEMENT LLC - HORIZON PHARMA PLC ownership

HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 2 filers reported holding HORIZON PHARMA PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 5.0%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of HORIZON PHARMA PLC
ValueSharesWeighting
Q2 2017$8,843,000
-75.0%
745,000
-68.9%
0.09%
-76.3%
Q1 2017$35,398,000
+258.6%
2,395,000
+292.6%
0.39%
+240.4%
Q4 2016$9,870,000610,0000.11%
Other shareholders
HORIZON PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 5,959,819$96,430,00010.71%
Consonance Capital Management LP 5,793,903$93,745,00010.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,956,988$144,924,0005.96%
JW Asset Management, LLC 507,075$8,205,0005.46%
KINGDON CAPITAL MANAGEMENT, L.L.C. 6,682,618$108,125,0005.23%
NEXTHERA CAPITAL LP 500,000$8,090,0004.74%
Lion Point Capital, LP 1,164,414$18,840,0004.58%
KINGDON CAPITAL MANAGEMENT, L.L.C. 4,503,900$72,873,0003.52%
ARMISTICE CAPITAL, LLC 650,000$10,517,0002.49%
SCOPIA CAPITAL MANAGEMENT LP 8,081,650$130,761,0002.48%
View complete list of HORIZON PHARMA PLC shareholders